Award

UL1TR002489

Funder: U.S. Department of Defense

Funded outputs count: 9

Funder award ID: UL1TR002489

OpenAlex ID: G2015897480

Reduced late endosome/lysosome function promotes SLE through chronic PI3K activity and SHP-1/SHIP-1 defects

2026 · SunAh Kang, Andrew J. Monteith, et al. · JCI Insight · 2

Asthma and COVID-19: Unveiling Outcome Disparities and Treatment Impact Based on Distinct Endotypes

2024 · Benjamin Sines, Cameron B. Morrison, et al. · Annals of the American Thoracic Society · 2

Impact of antiretroviral therapy during acute or early HIV infection on virologic and immunologic outcomes: results from a multinational clinical trial

2024 · Trevor A. Crowell, Justin Ritz, et al. · AIDS · 16

Expanding capabilities to evaluate readiness for return to duty after mTBI: The CAMP study protocol

2024 · Amy Seal Cecchini, Karen McCulloch, et al. · PLoS ONE · 5

Open-label study of the efficacy, safety, and durability of peanut sublingual immunotherapy in peanut-allergic children

2023 · Edwin H. Kim, Corinne A. Keet, et al. · Journal of Allergy and Clinical Immunology · 80

Environmental justice and allergic disease: A Work Group Report of the AAAAI Environmental Exposure and Respiratory Health Committee and the Diversity, Equity and Inclusion Committee

2022 · Allison J. Burbank, Michelle L. Hernandez, et al. · Journal of Allergy and Clinical Immunology · 65

Novel peanut-specific human IgE monoclonal antibodies enable screens for inhibitors of the effector phase in food allergy

2022 · Jada Suber, Yugen Zhang, et al. · Frontiers in Immunology · 11

Protocol design and synopsis: Omalizumab as Monotherapy and as Adjunct Therapy to Multiallergen OIT in Children and Adults with Food Allergy (OUtMATCH)

2022 · Robert A. Wood, R. Sharon Chinthrajah, et al. · Journal of Allergy and Clinical Immunology Global · 59

Role of miR-2392 in driving SARS-CoV-2 infection

2021 · J. Tyson McDonald, Francisco J. Enguita, et al. · Cell Reports · 96